BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9192985)

  • 61. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Yu LK; Zhang X
    Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Seemann O; Dienemann H; Schalhorn A; Prime G; Fink U
    Eur J Med Res; 1999 Aug; 4(8):313-27. PubMed ID: 10471543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
    Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
    Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Value of serum neuron-specific enolase in nonsmall cell lung cancer.
    Diez M; Torres A; Ortega L; Maestro M; Hernando F; Gomez A; Picardo A; Granell J; Balibrea JL
    Oncology; 1993; 50(2):127-31. PubMed ID: 8383830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.
    Cruz MJ; Curull V; Pijuan L; Álvarez-Simón D; Sánchez-Font A; de Gracia J; Culebras M; Ferrer J
    Arch Bronconeumol; 2017 Jun; 53(6):318-323. PubMed ID: 27914752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?
    Pina TC; Zapata IT; Hernández FC; López JB; Paricio PP; Hernández PM
    Clin Chim Acta; 2001 Mar; 305(1-2):27-34. PubMed ID: 11249919
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
    Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diagnostic usefulness of the determination of serum neuron-specific enolase in small cell bronchial carcinoma].
    Romero S; Padilla I; Mauri M; García-Sevila R; Martín C; Pérez-Carbonell A
    Med Clin (Barc); 1990 Jun; 95(1):10-4. PubMed ID: 2172670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract]   [Full Text] [Related]  

  • 74. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia.
    Metzgeroth G; Kripp M; Müller N; Schultheis B; Bonatz K; Walz C; Dorn-Beineke A; Hastka J
    Clin Chem Lab Med; 2009; 47(10):1291-5. PubMed ID: 19743956
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
    Shimokata K; Niwa Y; Yamamoto M; Sasou H; Morishita M
    Chest; 1989 Mar; 95(3):602-3. PubMed ID: 2537710
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
    Takada M; Kusunoki Y; Masuda N; Matui K; Yana T; Ushijima S; Iida K; Tamura K; Komiya T; Kawase I; Kikui N; Morino H; Fukuoka M
    Br J Cancer; 1996 May; 73(10):1227-32. PubMed ID: 8630283
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer.
    Zhou Q; Yang Z; Yang J; Tian Z; Zhang H
    J Surg Oncol; 1992 Jun; 50(2):121-4. PubMed ID: 1317485
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of serum p53 protein in lung cancer patients.
    Luo JC; Zehab R; Anttila S; Ridanpaa M; Husgafvel-Pursiainen K; Vainio H; Carney W; De Vivo I; Milling C; Brandt-Rauf PW
    J Occup Med; 1994 Feb; 36(2):155-60. PubMed ID: 8176513
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers.
    Charalabopoulos K; Karakosta A; Bablekos G; Golias C; Charalabopoulos A; Tsanou E; Peschos D; Zoganas L; Batistatou A
    Med Oncol; 2007; 24(2):219-25. PubMed ID: 17848747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.